SV Investment Corporation (289080) - Total Liabilities

Latest as of September 2025: ₩24.78 Billion KRW ≈ $16.80 Million USD

Based on the latest financial reports, SV Investment Corporation (289080) has total liabilities worth ₩24.78 Billion KRW (≈ $16.80 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does SV Investment Corporation generate cash to assess how effectively this company generates cash.

SV Investment Corporation - Total Liabilities Trend (2016–2024)

This chart illustrates how SV Investment Corporation's total liabilities have evolved over time, based on quarterly financial data. Check SV Investment Corporation liquid asset ratio to evaluate the company's liquid asset resilience ratio.

SV Investment Corporation Competitors by Total Liabilities

The table below lists competitors of SV Investment Corporation ranked by their total liabilities.

Company Country Total Liabilities
Sula Vineyards Limited
NSE:SULA
India Rs5.27 Billion
Financiera Independencia S.A.B. de C.V. SOFOM E.N.R
MX:FINDEP
Mexico MX$6.28 Billion
Forth Smart Service Public Company Limited
BK:FSMART
Thailand ฿1.91 Billion
Sermsang Power Corporation Public Company Limited
BK:SSP
Thailand ฿17.53 Billion
Ordinary Fully Paid Deferred Settlement
AU:BTRDA
Australia AU$41.10 Million
Karyopharm Therapeutics Inc
NASDAQ:KPTI
USA $365.49 Million
Intellego Technologies AB
ST:INT
Sweden Skr203.26 Million
Aroa Biosurgery Ltd
AU:ARX
Australia AU$14.34 Million

Liability Composition Analysis (2016–2024)

This chart breaks down SV Investment Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of SV Investment Corporation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.20 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.36 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.26 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SV Investment Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SV Investment Corporation (2016–2024)

The table below shows the annual total liabilities of SV Investment Corporation from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 ₩22.03 Billion
≈ $14.93 Million
+10.07%
2023-12-31 ₩20.02 Billion
≈ $13.57 Million
+175.99%
2022-12-31 ₩7.25 Billion
≈ $4.92 Million
-24.17%
2021-12-31 ₩9.57 Billion
≈ $6.48 Million
-33.92%
2020-12-31 ₩14.48 Billion
≈ $9.81 Million
+124.44%
2019-12-31 ₩6.45 Billion
≈ $4.37 Million
-22.37%
2018-12-31 ₩8.31 Billion
≈ $5.63 Million
-21.59%
2017-12-31 ₩10.60 Billion
≈ $7.18 Million
+5.90%
2016-12-31 ₩10.00 Billion
≈ $6.78 Million
--

About SV Investment Corporation

KQ:289080 Korea Asset Management
Market Cap
$157.20 Million
₩231.96 Billion KRW
Market Cap Rank
#17446 Global
#808 in Korea
Share Price
₩4280.00
Change (1 day)
+5.81%
52-Week Range
₩1470.00 - ₩4550.00
All Time High
₩7624.04
About

SV Investment Corporation is a private equity and venture capital firm. It considers investments in companies at early, mid, and late venture stages and private investments in public equities. The firm specializes in growth capital and buyouts. It also considers investments in healthcare, biotechnology, biopharmaceutical, cultural entertainment, technology, media, telecommunications, information … Read more